Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJD2H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,488
Award facts
- Contract value 100% obligated
- $14,487.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dupixent 200 mg/1.14 mL pen injectors valued at $14,487.54. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract that draws from AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 11, 2025.
This award exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, particularly supporting military and defense healthcare systems. As a major for-profit pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal contracts supplying branded and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military health personnel and veteran healthcare systems. The company's DLA Troop Support Medical IDC serves as a comprehensive global pharmaceutical vehicle enabling supply of critical medical products to support defense healthcare programs worldwide, positioning the company as a key vendor within the Defense Health Agency's medical procurement infrastructure.
Quick answers
Who was awarded contract SPE2DR26FJD2H?
SPE2DR26FJD2H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FJD2H worth?
The government has obligated $14,488 on SPE2DR26FJD2H.
Is contract SPE2DR26FJD2H an order under another contract?
Yes. SPE2DR26FJD2H is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJD2H competed?
The extent of competition for SPE2DR26FJD2H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award